4//SEC Filing
MCNAY JOSEPH C 4
Accession 0000914190-20-000222
CIK 0000707511other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:17 PM ET
Size
21.1 KB
Accession
0000914190-20-000222
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Award
Stock Option (right to buy)
2020-06-10+250,000→ 250,000 totalExercise: $0.30Exp: 2030-06-10→ Common Stock (250,000 underlying)
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $0.19Exp: 2022-02-11→ Common Stock (100,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying) - 120,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (120,000 underlying) - 6,524,122
Common Stock
- 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (104,167 underlying)- 78,125
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (78,125 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2029-05-15→ Common Stock (250,000 underlying)
Footnotes (5)
- [F1]100% vested.
- [F2]31,250 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F3]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
- [F4]62,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
- [F5]62,500 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001257674
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 6:17 PM ET
- Size
- 21.1 KB